Skip to search formSkip to main contentSkip to account menu

renal cancer metastatic

Known as: cancer metastatic renal, metastatic renal cancer 
National Institutes of Health

Related topics

Related topics

1 relation
renal metastasis

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2019
Review
2019
Influence of access on survival of renal cancer in a Brazilian center.
644 Background: The introduction of tyrosine kinase inhibitors (TKI) and recently immunotherapy has brought major survival… 
Review
2018
Review
2018
Traitement des métastases osseuses du cancer du rein
2016
2016
Corrigendum: Pazopanib in Metastatic Renal Cancer: A "Real-World" Experience at National Cancer Institute "Fondazione G. Pascale".
[This corrects the article on p. 287 in vol. 7, PMID: 27630568.]. 
2014
2014
Genito-urinary imaging Radiological evaluation of response to treatment : Application to metastatic renal cancers receiving anti-angiogenic treatment
2013
2013
Outcomes of patients with metastatic renal cell cancer treated with sunitinib in clinical practice at a reference cancer centre in Manchester, United Kingdom.
477 Background: The development of anti-angiogenic therapy produced a change in the treatment of metastatic renal cancer (mRCC… 
2012
2012
An indirect comparison of the toxicity of sunitinib and pazopanib in metastatic clear cell renal cancer.
2012
2012
Adherence to oral anticancer drugs (OAD) in patients (pts) with metastatic renal cancer (mRCC): First results of the prospective observational multicenter IPSOC study (Investigating Patient…
4622 Background: Patient adherence to oral therapy is a critical issue in cancer treatment. The aim of this study is to… 
2008
2008
Molekulare Therapie beim Nierenzellkarzinom
ZusammenfassungMolekulare Tumortherapeutika, „targeted therapy“ oder „kleine Moleküle“ haben in den letzten Jahren zu einer… 
Review
2004
Review
2004
Different measurement criteria give different tumor response classifications in patients with metastatic renal cancer (MRCC)
6013 Background: Since the publication of RECIST criteria (J Natl Cancer Inst. 2000), most investigators have used them, rather… 
Review
2004
Review
2004
Different measurement criteria give different tumor response classifications in patients with metastatic renal cancer (MRCC).
6013 Background: Since the publication of RECIST criteria (J Natl Cancer Inst. 2000), most investigators have used them, rather… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)